LivsMed Inc
LivsMed Inc is a South Korean medical equipment and supplies company that provides healthcare services and equipment to hospitals, clinics, and other healthcare facilities.
Business. LivsMed Inc is a healthcare company engaged in the medical equipment, supplies, and distribution industry. The firm operates within the Healthcare Services & Equipment sector, focusing on product sales. LivsMed Inc is headquartered in South Korea and is primarily listed on the KOSDAQ exchange under the ticker symbol 491000.KQ. Specific details regarding operating segments and geographic revenue mix are not disclosed.
Analyst recommendations
1 analysts · consensus BuyAt a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
LivsMed Inc is a healthcare company engaged in the medical equipment, supplies, and distribution industry. The firm operates within the Healthcare Services & Equipment sector, focusing on product sales. LivsMed Inc is headquartered in South Korea and is primarily listed on the KOSDAQ exchange under the ticker symbol 491000.KQ. Specific details regarding operating segments and geographic revenue mix are not disclosed.
LivsMed Inc has a highly liquid capital structure, with cash and equivalents of KRW 11.4 billion and a current ratio of 12.68, indicating strong short-term liquidity. However, the company has a negative net cash position after subtracting total debt, which is a key liquidity flag. The debt-to-equity ratio is low at 0.06, suggesting minimal leverage risk.
The company's profitability metrics are negative, with a return on equity of -12.65% and a return on assets of -11.33%, indicating significant underperformance relative to industry norms. The operating loss of KRW 2.26 billion and net loss of KRW 2.29 billion highlight the company's current financial distress. These results are far below the industry median for profitability metrics, suggesting operational inefficiencies or pricing pressures.
LivsMed Inc's revenue is concentrated in a single business segment, with no disclosed geographic diversification in the provided data. This lack of diversification increases exposure to sector-specific risks and limits growth opportunities.
The company's growth trajectory is uncertain, with no specific revenue growth projections provided in the data. The operating cash flow is negative at KRW 34.74 billion, and free cash flow is also negative at KRW 27.86 billion, indicating a lack of cash generation to support growth initiatives. Capital expenditures of KRW 7.72 billion suggest some investment in infrastructure, but the scale is insufficient to offset the operating losses.
The risk assessment indicates medium liquidity risk and low dilution risk. The negative net cash position is a key liquidity concern, but the low debt-to-equity ratio and high cash reserves mitigate some of the risk. No significant dilution sources are identified in the data, and the dilution potential is assessed as low.
Recent investor relations data shows a mean price target of KRW 140,000, with a median and high price target also at KRW 140,000. The mean recommendation is 2.00, indicating a "buy" rating, with one analyst issuing a "buy" recommendation and no strong buy or hold ratings. This suggests limited analyst confidence in the company's near-term prospects.
- LivsMed Inc has strong liquidity but is currently unprofitable with significant operating and net losses.
- The company's capital structure is highly liquid, with a low debt-to-equity ratio and high cash reserves.
- Profitability metrics are far below industry norms, indicating operational challenges.
- The company's revenue is concentrated in a single segment, increasing exposure to sector-specific risks.
- Analysts have issued a "buy" rating, but with limited consensus and no strong buy recommendations.
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Consensus distribution
sell-side coverageEstimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- LivsMed Inc Market data — financials · 2026-05-26
- LivsMed Inc Market data — analyst estimates · 2026-05-26